EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access

Pooled Efficacy and Safety of Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulants or Antiplatelets: A Meta‐Analysis of the Landmark Randomized Trials

Leonardo M Knijnik iD, Birju Rao iD, David B DeLurgio

Journal of Cardiovascular Electrophysiology · 2026-09 · 37 (9) · 2122-2123

DOI: 10.1111/jce.70493 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 03.09.2026. Verfasst von Leonardo M Knijnik und 2 weiteren Autor:innen. Beteiligte Einrichtung: Emory University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Left Atrial Appendage Closure, Atrial Fibrillation, Stroke, Anticoagulants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Landmark randomized controlled trials (RCTs) comparing left atrial appendage occlusion (LAAO) against direct oral anticoagulants (DOACs) are individually underpowered for small but clinically meaningful differences. We performed a pooled meta‐analysis to provide more precise efficacy and safety data.

Methods

Utilizing random‐effects models, we pooled data from 5890 patients across four landmark RCTs (PRAGUE‐17, CLOSURE‐AF, OPTION, and CHAMPION‐AF) at their longest follow‐up.

Results

There were no significant differences between LAAO and antithrombotics in cardiovascular mortality (5.3% vs. 4.8%, p = 0.33), all‐cause stroke (3.3% vs. 2.8%, p = 0.31), systemic embolism (0.2% vs. 0.1%, p = 0.68), or major bleeding (6.6% vs. 6.8%, p = 0.85). Non‐procedural bleeding was significantly lower with LAAO (9.2% vs. 16.7%; RR 0.55; 95% CI 0.47–0.64; p < 0.0001), though there was a numerical trend toward more ischemic stroke events (2.7% vs. 2.0%; RR 1.35; 95% CI 0.97–1.88; p = 0.08).

Conclusion

LAAO offers similar overall efficacy and safety to modern antithrombotics. It represents a clinical trade‐off: accepting a known upfront procedural risk for a robust, long‐term reduction in non‐procedural bleeding, potentially at the cost of a slight numerical increase in ischemic stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Left Atrial Appendage ClosureAtrial FibrillationStrokeAnticoagulantsPlatelet Aggregation InhibitorsAtrial AppendageHumansTreatment OutcomeRandomized Controlled Trials as TopicAdministration, OralRisk FactorsHemorrhageFemaleTime FactorsMaleAgedRisk Assessment

Substanzen

AnticoagulantsPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Emory University, Atlanta, Georgia, USA.

ORCID-Profile: Leonardo M Knijnik, Birju Rao

Zitieren

APA

Knijnik, L. M., Rao, B., & DeLurgio, D. B. (2026). Pooled Efficacy and Safety of Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulants or Antiplatelets: A Meta‐Analysis of the Landmark Randomized Trials. Journal of Cardiovascular Electrophysiology, 37(9), 2122-2123. https://doi.org/10.1111/jce.70493

Vancouver

Knijnik LM, Rao B, DeLurgio DB. Pooled Efficacy and Safety of Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulants or Antiplatelets: A Meta‐Analysis of the Landmark Randomized Trials. Journal of Cardiovascular Electrophysiology. 2026;37(9):2122-2123. doi:10.1111/jce.70493

BibTeX
@article{Knijnik2026,
  author = {Knijnik, Leonardo M and Rao, Birju and DeLurgio, David B},
  title = {Pooled Efficacy and Safety of Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulants or Antiplatelets: A Meta‐Analysis of the Landmark Randomized Trials},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2026},
  volume = {37},
  number = {9},
  pages = {2122--2123},
  doi = {10.1111/jce.70493}
}
Kostenlos starten →